前沿生物-U
(688221)
| 流通市值：63.19亿 | | | 总市值：63.19亿 |
| 流通股本：3.75亿 | | | 总股本：3.75亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 393,226,977.92 | 187,601,398.98 | 170,344,359.37 | 97,399,221.59 |
| 交易性金融资产 | 317,855,418.01 | 542,118,782.54 | 542,794,210.66 | 594,745,179.92 |
| 衍生金融资产 | 4,230,233.18 | - | - | - |
| 应收票据及应收账款 | 34,091,215.21 | 43,290,858.04 | 58,493,284.52 | 62,906,181.25 |
| 其中：应收票据 | 1,000,160 | 4,911,211 | - | 3,621,455 |
| 应收账款 | 33,091,055.21 | 38,379,647.04 | 58,493,284.52 | 59,284,726.25 |
| 预付款项 | 23,945,086.82 | 19,522,702.36 | 10,072,621.59 | 10,726,540.36 |
| 其他应收款合计 | 134,621,346.07 | 134,150,238.41 | 133,600,024.86 | 219,289,873.77 |
| 其中:应收利息 | 11,074,461.71 | 9,795,211.7 | 8,615,143.71 | 8,539,744.86 |
| 存货 | 65,431,947.76 | 78,198,818.37 | 66,620,799.93 | 48,509,627.4 |
| 其他流动资产 | 220,144,848.24 | 282,935,017.15 | 22,892,868.97 | 22,324,401.94 |
| 流动资产合计 | 1,193,547,073.21 | 1,287,817,815.85 | 1,004,818,169.9 | 1,055,901,026.23 |
| 非流动资产: | | | | |
| 长期股权投资 | 21,552,802.95 | 20,694,232.45 | 21,265,016.14 | 17,602,634.93 |
| 投资性房地产 | 3,510,187.72 | - | - | - |
| 固定资产 | 410,325,442.21 | 416,298,931.21 | 422,408,594.02 | 426,669,436.06 |
| 在建工程 | 381,946.91 | 381,946.91 | 405,221.24 | 2,362,123.9 |
| 使用权资产 | 319,806.54 | 703,573.63 | 415,604.45 | 326,966.04 |
| 无形资产 | 113,296,484.18 | 122,177,815.7 | 127,553,508.18 | 132,938,433.63 |
| 长期待摊费用 | 1,909,454.53 | 2,036,115.67 | 1,444,400.18 | 1,589,768.73 |
| 其他非流动资产 | 740,630 | 340,500 | - | - |
| 非流动资产合计 | 552,036,755.04 | 562,633,115.57 | 573,492,344.21 | 581,489,363.29 |
| 资产总计 | 1,745,583,828.25 | 1,850,450,931.42 | 1,578,310,514.11 | 1,637,390,389.52 |
| 流动负债: | | | | |
| 短期借款 | 136,138,874.14 | 285,316,201.01 | 249,713,438.74 | 226,956,380.54 |
| 应付票据及应付账款 | 29,966,919.04 | 30,807,252.17 | 47,060,713.89 | 29,840,778.08 |
| 应付账款 | 29,966,919.04 | 30,807,252.17 | 47,060,713.89 | 29,840,778.08 |
| 预收款项 | 5,000 | 20,000 | 35,000 | 50,000 |
| 合同负债 | 40,175,927.86 | 12,587,669.3 | 1,780,595.62 | 1,820,247.11 |
| 应付职工薪酬 | 11,904,566.58 | 10,625,663.17 | 18,523,508.13 | 18,609,905.7 |
| 应交税费 | 1,077,766.88 | 1,151,914.53 | 932,667.9 | 870,059.75 |
| 其他应付款合计 | 7,114,546.85 | 9,682,268.65 | 15,945,990.92 | 18,352,384.63 |
| 一年内到期的非流动负债 | 14,403,404.62 | 13,534,000 | 76,333,413.16 | 93,896,507.62 |
| 其他流动负债 | 11,086.42 | 56,915.99 | 14,010.46 | 25,090.52 |
| 流动负债合计 | 240,798,092.39 | 363,781,884.82 | 410,339,338.82 | 390,421,353.95 |
| 非流动负债: | | | | |
| 长期借款 | 268,880,411.71 | 172,505,891 | 82,855,241.19 | 53,487,600 |
| 租赁负债 | - | 236,471.41 | - | - |
| 长期应付款 | 147,626,540.64 | 147,626,540.64 | 147,626,540.64 | 147,626,540.64 |
| 预计负债 | 973,205.62 | 1,637,918.07 | 1,587,196.45 | 2,352,034.28 |
| 递延收益 | 53,435,296.91 | 56,384,350.96 | 59,033,405.01 | 61,982,459.06 |
| 非流动负债合计 | 470,915,454.88 | 378,391,172.08 | 291,102,383.29 | 265,448,633.98 |
| 负债合计 | 711,713,547.27 | 742,173,056.9 | 701,441,722.11 | 655,869,987.93 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 374,578,653 | 374,578,653 | 374,578,653 | 374,578,653 |
| 资本公积 | 2,734,780,198.66 | 2,730,761,484.95 | 2,726,786,932.91 | 2,723,191,887.05 |
| 其他综合收益 | 116,736.4 | 78,916.5 | 38,140.2 | 40,289.69 |
| 未分配利润 | -2,075,605,307.08 | -1,997,141,179.93 | -2,224,534,934.11 | -2,116,290,428.15 |
| 归属于母公司股东权益合计 | 1,033,870,280.98 | 1,108,277,874.52 | 876,868,792 | 981,520,401.59 |
| 股东权益合计 | 1,033,870,280.98 | 1,108,277,874.52 | 876,868,792 | 981,520,401.59 |
| 负债和股东权益合计 | 1,745,583,828.25 | 1,850,450,931.42 | 1,578,310,514.11 | 1,637,390,389.52 |
| 公告日期 | 2026-08-31 | 2026-04-25 | 2026-04-25 | 2025-10-31 |
| 审计意见(境内) | | | 标准无保留意见 | |